Metagenomi Therapeutics (MGX) traded down -1.23 % during a 24 hours period ending at 04:55 PM Central Europe on Monday 26th. One Metagenomi Therapeutics stock can currently be bought for about USD 0.82 on popular exchanges. Current supply of Metagenomi Therapeutics stocks is 37.8 mn. Metagenomi Therapeutics has a current market capitalization of USD 30.4 mn and approximately USD 61.8 k worth of Metagenomi Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Metagenomi Therapeutics has traded -29.91 % down. Simple moving average of last 200 days is at USD 1.32. The highest price of past 52 weeks was recorded at USD 2.78 on 10/28/2025. 52 weeks low was at USD 0.77 on 10/16/2026.
Here is how related stocks have performed in the past 24 hours:
Microvision (MVIS) traded up 3.51 % and now trades at USD 1.2. Current market capitalisation for Microvision is USD 36.1 mn.
Star Equity (STRR) traded flat 0 % and now trades at USD 9.8. Star Equity has a market capitalisation of USD 35.8 mn.
Biote (BTMD) traded down -1.83 % and now trades at USD 1.06. Biote has a market capitalisation of USD 36.3 mn.
Precipio (PRPO) traded down -2.91 % and now trades at USD 19.3. Precipio has a market capitalisation of USD 35.8 mn.
Cryo-cell (CCEL) traded down -0.67 % and now trades at USD 4.93. Current market capitalisation for Cryo-cell is USD 35.9 mn.
About Metagenomi Therapeutics
Metagenomi Inc. is an American biotechnology company with its IPO scheduled to take place on February 8, 2024, on the Nasdaq stock exchange.
